| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.826 | 0.003 | 0.826 | Diuretic | 0.807 0.003 DBMET01142 | ||
| 0.622 | 0.002 | 0.706 | Angiotensin-converting enzyme inhibitor | 0.706 0.002 DBMET01142 | DBMET01142 | |
| 0.584 | 0.007 | 0.584 | Vasodilator | 0.581 0.007 DBMET01142 | ||
| 0.477 | 0.019 | 0.477 | Vasodilator, coronary | 0.389 0.039 DBMET01142 | ||
| 0.355 | 0.002 | 0.414 | Angiotensin-converting enzyme 2 inhibitor | 0.414 0.002 DBMET01142 | DBMET01142 | |
| 0.379 | 0.055 | 0.379 | Antithrombotic | 0.351 0.064 DBMET01142 | ||
| 0.37 | 0.059 | 0.37 | Immunostimulant | 0.357 0.062 DBMET01142 | ||
| 0.366 | 0.067 | 0.442 | Vasodilator, peripheral | 0.442 0.043 DBMET01142 | DBMET01142 | |
| 0.276 | 0.028 | 0.328 | Thrombolytic | 0.328 0.02 DBMET01142 | DBMET01142 | |
| 0.292 | 0.055 | 0.327 | Platelet antagonist | 0.327 0.044 DBMET01142 | DBMET01142 | |
| 0.248 | 0.012 | 0.266 | Neurotrophic factor | 0.266 0.01 DBMET01142 | DBMET01142 | |
| 0.303 | 0.071 | 0.369 | Interleukin 2 agonist | 0.369 0.038 DBMET01142 | DBMET01142 | |
| 0.29 | 0.061 | 0.29 | Cardiotonic | 0.268 0.071 DBMET01142 | ||
| 0.23 | 0.008 | 0.355 | Metalloproteinase-2 inhibitor | 0.355 0.004 DBMET01142 | DBMET01142 | |
| 0.237 | 0.015 | 0.282 | Aminopeptidase B inhibitor | 0.282 0.01 DBMET01142 | DBMET01142 | |
| 0.341 | 0.123 | 0.341 | 5 Hydroxytryptamine release inhibitor | |||
| 0.275 | 0.059 | 0.298 | Angiogenesis stimulant | 0.298 0.05 DBMET01142 | DBMET01142 | |
| 0.343 | 0.128 | 0.368 | Cyclophilin D inhibitor | 0.368 0.11 DBMET01142 | DBMET01142 | |
| 0.24 | 0.029 | 0.24 | Thiol protease inhibitor | 0.215 0.035 DBMET01142 | ||
| 0.272 | 0.078 | 0.277 | Insulysin inhibitor | 0.277 0.074 DBMET01142 | DBMET01142 | |
| 0.22 | 0.046 | 0.254 | Anticoagulant | 0.254 0.038 DBMET01142 | DBMET01142 | |
| 0.244 | 0.083 | 0.278 | Interleukin agonist | 0.278 0.06 DBMET01142 | DBMET01142 | |
| 0.27 | 0.112 | 0.27 | Cholesterol antagonist | 0.186 0.178 DBMET01142 | ||
| 0.194 | 0.061 | 0.272 | Growth hormone agonist | 0.272 0.038 DBMET01142 | DBMET01142 | |
| 0.219 | 0.096 | 0.219 | Hypoglycemic | 0.183 0.13 DBMET01142 | ||
| 0.136 | 0.028 | 0.179 | Folate antagonist | 0.179 0.014 DBMET01142 | DBMET01142 | |
| 0.104 | 0.005 | 0.108 | Prolyl endopeptidase inhibitor | 0.108 0.005 DBMET01142 | DBMET01142 | |
| 0.107 | 0.017 | 0.107 | Elastase 1 inhibitor | 0.092 0.025 DBMET01142 | ||
| 0.131 | 0.045 | 0.131 | Mucolytic | 0.12 0.054 DBMET01142 | ||
| 0.088 | 0.008 | 0.107 | HCV NS3/NS4A protease inhibitor | 0.107 0.004 DBMET01142 | DBMET01142 | |
| 0.16 | 0.08 | 0.184 | Neurotensin receptor agonist | 0.184 0.046 DBMET01142 | DBMET01142 | |
| 0.266 | 0.188 | 0.266 | Calcium channel L-type activator | |||
| 0.101 | 0.027 | 0.177 | Aminopeptidase I inhibitor | 0.177 0.009 DBMET01142 | DBMET01142 | |
| 0.076 | 0.013 | 0.076 | Leukocyte elastase inhibitor | 0.049 0.025 DBMET01142 | ||
| 0.169 | 0.109 | 0.173 | Insulin sensitizer | 0.173 0.103 DBMET01142 | DBMET01142 | |
| 0.186 | 0.132 | 0.186 | Spasmolytic | |||
| 0.073 | 0.02 | 0.073 | Elastase inhibitor | 0.07 0.022 DBMET01142 | ||
| 0.106 | 0.061 | 0.106 | Protease inhibitor | 0.101 0.065 DBMET01142 | ||
| 0.092 | 0.047 | 0.106 | Factor XII inhibitor | 0.106 0.032 DBMET01142 | DBMET01142 | |
| 0.152 | 0.108 | 0.152 | Hepatoprotectant | 0.138 0.123 DBMET01142 | ||
| 0.051 | 0.008 | 0.066 | Glutamate (mGluR8) antagonist | 0.066 0.004 DBMET01142 | DBMET01142 | |
| 0.088 | 0.046 | 0.088 | Chymotrypsin inhibitor | 0.083 0.05 DBMET01142 | ||
| 0.085 | 0.046 | 0.097 | Somatostatin 1 agonist | 0.097 0.036 DBMET01142 | DBMET01142 | |
| 0.19 | 0.154 | 0.208 | Tyrosine 3 hydroxylase inhibitor | 0.208 0.122 DBMET01142 | DBMET01142 | |
| 0.08 | 0.044 | 0.091 | Cathepsin G inhibitor | 0.091 0.037 DBMET01142 | DBMET01142 | |
| 0.093 | 0.06 | 0.1 | Falcipain inhibitor | 0.1 0.055 DBMET01142 | DBMET01142 | |
| 0.066 | 0.033 | 0.071 | Cathepsin E inhibitor | 0.071 0.029 DBMET01142 | DBMET01142 | |
| 0.089 | 0.057 | 0.089 | Ornithine decarboxylase inhibitor | 0.076 0.071 DBMET01142 | ||
| 0.041 | 0.009 | 0.062 | Neutral endopeptidase inhibitor | 0.062 0.006 DBMET01142 | DBMET01142 | |
| 0.216 | 0.185 | 0.216 | Histamine release inhibitor | |||
| 0.089 | 0.06 | 0.096 | Falcipain 2 inhibitor | 0.096 0.055 DBMET01142 | DBMET01142 | |
| 0.056 | 0.027 | 0.073 | Metalloproteinase-3 inhibitor | 0.073 0.018 DBMET01142 | DBMET01142 | |
| 0.098 | 0.071 | 0.098 | Expectorant | 0.091 0.08 DBMET01142 | ||
| 0.061 | 0.034 | 0.061 | Human rhinovirus A protease inhibitor | 0.056 0.038 DBMET01142 | ||
| 0.144 | 0.121 | 0.157 | Psychostimulant | 0.157 0.11 DBMET01142 | DBMET01142 | |
| 0.103 | 0.084 | 0.129 | Cell adhesion inhibitor | 0.129 0.059 DBMET01142 | DBMET01142 | |
| 0.031 | 0.013 | 0.053 | Angiotensin AT2 receptor antagonist | 0.053 0.009 DBMET01142 | DBMET01142 | |
| 0.055 | 0.038 | 0.072 | Matrix metalloproteinase (membrane-type) inhibitor | 0.072 0.024 DBMET01142 | DBMET01142 | |
| 0.047 | 0.03 | 0.075 | Neurotensin receptor antagonist | 0.075 0.019 DBMET01142 | DBMET01142 | |
| 0.062 | 0.048 | 0.062 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.039 | 0.026 | 0.043 | Leukotriene A4 hydrolase inhibitor | 0.043 0.023 DBMET01142 | DBMET01142 | |
| 0.08 | 0.07 | 0.1 | Opioid antagonist | 0.1 0.047 DBMET01142 | DBMET01142 | |
| 0.094 | 0.085 | 0.096 | Factor V inhibitor | 0.096 0.08 DBMET01142 | DBMET01142 | |
| 0.033 | 0.024 | 0.042 | Calcitonin receptor agonist | 0.042 0.019 DBMET01142 | DBMET01142 | |
| 0.026 | 0.02 | 0.066 | Lysine carboxypeptidase inhibitor | 0.066 0.005 DBMET01142 | DBMET01142 | |
| 0.032 | 0.027 | 0.037 | Angiotensin II receptor antagonist | 0.037 0.018 DBMET01142 | DBMET01142 | |
| 0.066 | 0.061 | 0.069 | Thrombin inhibitor | 0.069 0.056 DBMET01142 | DBMET01142 | |
| 0.071 | 0.067 | 0.087 | Cell adhesion molecule inhibitor | 0.087 0.045 DBMET01142 | DBMET01142 | |
| 0.044 | 0.04 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.028 DBMET01142 | DBMET01142 | |
| 0.021 | 0.02 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.017 DBMET01142 | DBMET01142 | |
| 0.027 | 0.027 | 0.036 | Caspase 2 inhibitor | 0.036 0.018 DBMET01142 | DBMET01142 | |
| 0.035 | 0.037 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.016 DBMET01142 | DBMET01142 | |
| 0.056 | 0.058 | 0.058 | Caspase 9 inhibitor | 0.058 0.051 DBMET01142 | DBMET01142 | |
| 0.078 | 0.081 | 0.087 | Hematopoietic | 0.087 0.055 DBMET01142 | DBMET01142 | |
| 0.051 | 0.055 | 0.084 | Glucagon-like peptide 1 agonist | 0.084 0.032 DBMET01142 | DBMET01142 | |
| 0.022 | 0.029 | 0.027 | Bradykinin B2 receptor agonist | 0.027 0.022 DBMET01142 | DBMET01142 | |
| 0.055 | 0.063 | 0.057 | Trypsin inhibitor | 0.057 0.055 DBMET01142 | DBMET01142 | |
| 0.037 | 0.046 | 0.049 | GP IIb/IIIa receptor antagonist | 0.049 0.033 DBMET01142 | DBMET01142 | |
| 0.044 | 0.054 | 0.057 | Aminopeptidase microsomal inhibitor | 0.057 0.042 DBMET01142 | DBMET01142 | |
| 0.045 | 0.059 | 0.069 | Opioid delta receptor antagonist | 0.069 0.041 DBMET01142 | DBMET01142 | |
| 0.051 | 0.065 | 0.076 | Matrix metalloproteinase inhibitor | 0.076 0.04 DBMET01142 | DBMET01142 | |
| 0.098 | 0.112 | 0.155 | Cathepsin H inhibitor | 0.155 0.043 DBMET01142 | DBMET01142 | |
| 0.04 | 0.057 | 0.049 | Collagenase inhibitor | 0.049 0.035 DBMET01142 | DBMET01142 | |
| 0.173 | 0.19 | 0.238 | Gastrin inhibitor | 0.238 0.094 DBMET01142 | DBMET01142 | |
| 0.01 | 0.028 | 0.024 | Aminopeptidase A inhibitor | 0.024 0.008 DBMET01142 | DBMET01142 | |
| 0.014 | 0.033 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.014 DBMET01142 | DBMET01142 | |
| 0.032 | 0.052 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.036 DBMET01142 | DBMET01142 | |
| 0.021 | 0.045 | 0.029 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.029 0.016 DBMET01142 | DBMET01142 | |
| 0.033 | 0.06 | 0.041 | VCAM-1 antagonist | 0.041 0.023 DBMET01142 | DBMET01142 | |
| 0.033 | 0.06 | 0.041 | VCAM antagonist | 0.041 0.023 DBMET01142 | DBMET01142 | |
| 0.027 | 0.056 | 0.032 | HCV polyprotein inhibitor | 0.032 0.029 DBMET01142 | DBMET01142 | |
| 0.063 | 0.092 | 0.074 | Opioid kappa receptor antagonist | 0.074 0.067 DBMET01142 | DBMET01142 | |
| 0.021 | 0.056 | 0.047 | Complement C3a chemotactic receptor antagonist | 0.047 0.028 DBMET01142 | DBMET01142 | |
| 0.072 | 0.107 | 0.115 | Falcipain 3 inhibitor | 0.115 0.057 DBMET01142 | DBMET01142 | |
| 0.027 | 0.064 | 0.039 | Integrin alpha5beta1 antagonist | 0.039 0.031 DBMET01142 | DBMET01142 | |
| 0.1 | 0.143 | 0.119 | Protein-tyrosine phosphatase inhibitor | 0.119 0.115 DBMET01142 | DBMET01142 | |
| 0.009 | 0.052 | 0.021 | Integrin alpha4 antagonist | 0.021 0.02 DBMET01142 | DBMET01142 | |
| 0.013 | 0.058 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET01142 | DBMET01142 | |
| 0.026 | 0.075 | 0.047 | Matrix metalloproteinase 1 inhibitor | 0.047 0.041 DBMET01142 | DBMET01142 | |
| 0.017 | 0.069 | 0.042 | Integrin antagonist | 0.042 0.03 DBMET01142 | DBMET01142 | |
| 0.025 | 0.077 | 0.046 | Ribonucleoside-diphosphate reductase inhibitor | 0.046 0.044 DBMET01142 | DBMET01142 | |
| 0.174 | 0.227 | 0.236 | Sodium/bile acid cotransporter inhibitor | 0.236 0.144 DBMET01142 | DBMET01142 | |
| 0.005 | 0.073 | 0.022 | VLA-4 antagonist | 0.022 0.02 DBMET01142 | DBMET01142 | |
| 0.016 | 0.095 | 0.04 | Histone deacetylase 8 inhibitor | 0.04 0.029 DBMET01142 | DBMET01142 | |
| 0.035 | 0.141 | 0.062 | NMDA receptor agonist | 0.062 0.044 DBMET01142 | DBMET01142 | |
| 0.051 | 0.181 | 0.11 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.11 0.046 DBMET01142 | DBMET01142 | |
| 0.13 | 0.377 | 0.189 | 5 Hydroxytryptamine uptake stimulant | 0.189 0.176 DBMET01142 | DBMET01142 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |